Quart Barry D

USNatural personDirector

Transactions

255

Issuers

Buys / Sells

3/34

Last tx

28 Apr 2026

FrançaisSign in Try free 14d

Insider

Quart Barry D

USNatural personDirector

Transactions

255

Issuers

Buys / Sells

3/34

Last tx

28 Apr 2026

Behaviour

1 purchase reported after at least 12 months of silence — most recent on 03 Oct 2019.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
HERON THERAPEUTICS, INC. /DE/	850,000	reported	18 Jan 2023	tx 94+27,598,777−3,494,212
Kiniksa Pharmaceuticals International, plc	25,645	reported	28 Apr 2026	tx 50+292,117−215,336
TRIMERIS INC	0	reported	22 Jun 2015	tx 37+198,375−132,876
INTRABIOTICS PHARMACEUTICALS INC /DE	0	reported	19 Jun 2012	tx 75+1,452,500−1,453,848

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	13,099	14.33 USD	10b5-1
28 Apr 2026	SALE	Kiniksa Pharmaceuticals International, plc	13,099	50.10 USD	10b5-1
28 Apr 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	13,099	0.00 USD	10b5-1deriv
12 Feb 2026	SALE	Kiniksa Pharmaceuticals International, plc	2,690	45.00 USD
12 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,690	15.47 USD
10 Feb 2026	SALE	Kiniksa Pharmaceuticals International, plc	110	45.00 USD
10 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	110	15.47 USD
10 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	110	0.00 USD	deriv
12 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,690	0.00 USD	deriv
02 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	830	15.47 USD
02 Feb 2026	SALE	Kiniksa Pharmaceuticals International, plc	830	45.00 USD
03 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	12,528	15.47 USD
03 Feb 2026	SALE	Kiniksa Pharmaceuticals International, plc	12,528	45.27 USD
04 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,602	15.47 USD
04 Feb 2026	SALE	Kiniksa Pharmaceuticals International, plc	2,602	45.02 USD
04 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	2,602	0.00 USD	deriv
02 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	830	0.00 USD	deriv
03 Feb 2026	EXERCISE	Kiniksa Pharmaceuticals International, plc	12,528	0.00 USD	deriv
15 Dec 2025	SALE	Kiniksa Pharmaceuticals International, plc	20,129	41.51 USD
15 Dec 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	20,129	10.36 USD
15 Dec 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	20,129	0.00 USD	deriv
09 Jun 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	6,900	3.80 USD
09 Jun 2025	SALE	Kiniksa Pharmaceuticals International, plc	6,900	30.26 USD
10 Jun 2025	SALE	Kiniksa Pharmaceuticals International, plc	8,212	30.36 USD
11 Jun 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	12,336	3.80 USD

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
HERON THERAPEUTICS, INC. /DE/	850,000	reported	18 Jan 2023	tx 94+27,598,777−3,494,212
Kiniksa Pharmaceuticals International, plc	25,645	reported	28 Apr 2026	tx 50+292,117−215,336
TRIMERIS INC	0	reported	22 Jun 2015	tx 37+198,375−132,876
INTRABIOTICS PHARMACEUTICALS INC /DE	0	reported	19 Jun 2012	tx 75+1,452,500−1,453,848